Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIPER-SHOCK: OctaplasLG vs Crystalloids in Septic Shock
NCT03092245Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of octaplas lg in septic shock, sponsored by Rigshospitalet. Started Apr 2017; status: completed.
02
Drugs
octaplas lg
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03092245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092245.